ASSOCIATED BANC-CORP - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
ASSOCIATED BANC-CORP ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$921,017
-1.7%
9,042
-2.6%
0.04%
+2.9%
Q2 2023$936,646
+8.8%
9,282
-0.8%
0.04%0.0%
Q1 2023$861,120
+3.5%
9,360
+2.0%
0.04%0.0%
Q4 2022$832,355
+19.8%
9,175
+0.3%
0.04%
+9.4%
Q3 2022$695,000
-12.2%
9,148
-2.3%
0.03%
-8.6%
Q2 2022$792,000
-7.8%
9,363
-4.4%
0.04%
+6.1%
Q1 2022$859,000
-3.9%
9,794
-4.1%
0.03%0.0%
Q4 2021$894,000
+5.8%
10,218
-1.2%
0.03%0.0%
Q3 2021$845,000
-13.5%
10,343
-3.3%
0.03%
-15.4%
Q2 2021$977,000
-4.4%
10,699
-13.7%
0.04%
-39.1%
Q1 2021$1,022,000
-6.1%
12,402
+7.6%
0.06%
+52.4%
Q4 2020$1,088,000
+6.1%
11,527
-2.3%
0.04%
-4.5%
Q3 2020$1,025,000
-6.0%
11,794
-5.6%
0.04%
-10.2%
Q2 2020$1,091,000
+5.8%
12,490
-0.2%
0.05%
-10.9%
Q1 2020$1,031,000
-4.9%
12,510
+9.4%
0.06%
+1.9%
Q4 2019$1,084,000
+8.0%
11,440
-1.0%
0.05%0.0%
Q3 2019$1,004,000
-10.0%
11,555
-5.4%
0.05%
-11.5%
Q2 2019$1,115,000
-9.9%
12,209
-5.2%
0.06%
-14.1%
Q1 2019$1,238,000
+10.4%
12,873
-1.5%
0.07%
-2.7%
Q4 2018$1,121,000
+0.4%
13,063
+0.8%
0.07%
+17.7%
Q3 2018$1,116,000
-35.6%
12,960
-43.5%
0.06%
-38.6%
Q2 2018$1,732,000
-7.7%
22,932
-1.2%
0.10%
-5.6%
Q1 2018$1,876,000
-10.4%
23,202
-7.0%
0.11%
-5.3%
Q4 2017$2,094,000
-5.2%
24,940
-3.1%
0.11%
-7.4%
Q3 2017$2,209,000
-3.4%
25,730
-6.1%
0.12%
-6.2%
Q2 2017$2,287,000
-12.1%
27,401
-21.8%
0.13%
-16.1%
Q1 2017$2,601,000
-0.3%
35,022
-2.2%
0.16%
-4.9%
Q4 2016$2,608,000
-11.1%
35,806
-3.7%
0.16%
-12.8%
Q3 2016$2,934,000
-5.6%
37,170
-1.3%
0.19%
-6.5%
Q2 2016$3,107,000
+13.9%
37,662
+0.0%
0.20%
+11.7%
Q1 2016$2,728,000
-19.3%
37,657
-4.1%
0.18%
-19.7%
Q4 2015$3,381,000
-7.4%
39,287
-1.1%
0.22%
-12.5%
Q3 2015$3,652,000
-7.6%
39,726
-1.1%
0.26%
+0.8%
Q2 2015$3,951,000
-2.8%
40,176
-2.6%
0.25%
-1.6%
Q1 2015$4,066,000
+3.2%
41,231
-3.0%
0.26%
+3.6%
Q4 2014$3,939,000
-8.9%
42,514
-7.4%
0.25%
-12.7%
Q3 2014$4,322,000
+3.3%
45,914
-0.7%
0.28%
+4.4%
Q2 2014$4,184,000
+4.4%
46,220
-2.0%
0.27%
-1.4%
Q1 2014$4,009,000
+6.6%
47,157
+0.8%
0.28%
+2.2%
Q4 2013$3,760,000
+4.9%
46,783
+0.2%
0.27%
-4.9%
Q3 2013$3,583,000
+2.7%
46,708
-5.3%
0.28%
-1.0%
Q2 2013$3,488,00049,3250.29%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders